COVID-19 and Diabetes Mellitus: A Complex Interplay
| Autor: | Gopala Koneru, Hager H. Sayed, Nayera A. Abd-elhamed, Nouran Elsedfy, Amira H. Mohamed, Hania A. Abdellatif, Fatmaalzharaa F. Mohamed, Esraa H. Bahnasawy, Nayera K. Mousa, Aml Eisa, Esraa A. Elshenawy, Yassmin Z. Basheer, Esraa H. Sayed, Farah F. Mohamed, Walaa R. Ali, Hadir A. Soliman, Ashrakt A. Eltabary, Noorhan M. Sayed, Nourhan H. Nasr, Nour S. Khairallah, Helal F. Hetta |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Journal of Pure and Applied Microbiology, Vol 15, Iss 2, Pp 512-523 (2021) |
| Druh dokumentu: | article |
| ISSN: | 0973-7510 2581-690X |
| DOI: | 10.22207/JPAM.15.2.16 |
| Popis: | COVID-19 pandemic, which caused by the newly emerged severe acute respiratory syndrome coronavirus-2 (SARS- CoV-2), puts the entire world in an unprecedented crisis, leaving behind huge human losses and serious socio-economical damages. The clinical spectrum of COVID-19 varies from asymptomatic to multi-organ manifestations. Diabetes mellitus (DM) is a chronic inflammatory condition, which associated with metabolic and vascular abnormalities, increases the risk for SARS-CoV-2 infection, severity and mortality. Due to global prevalence, DM effect on COVID-19 outcomes as well as the potential mechanisms by which DM modulates the host-viral interactions and host-immune responses are discussed in this review. This review also highlights the effects of anti-diabetic drugs on treatment of SARS-CoV-2 infection and vice versa. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|